Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 22, 2026
Why Is Pegasystems (PEGA) Stock Down -13.99% Today?

Why Is Pegasystems (PEGA) Stock Down -13.99% Today?

Key Takeaways

  • Pegasystems shares plunged approximately 14% in Wednesday's session following a disappointing second-quarter 2026 earnings report released after Tuesday's close.
  • Primary catalyst: Q2 adjusted EPS of $0.35 missed the $0.43 consensus by $0.08, while revenue of $420.72 million fell short of the $427.38 million analyst estimate.
  • Secondary drivers: Annual Contract Value (ACV) growth decelerated to 7% year-over-year from 12% in the prior quarter, and management warned that "unprecedented changes in the AI market" were causing enterprise clients to delay purchasing decisions.
  • Analyst downgrade: Citizens JMP cut its rating on PEGA from Market Outperform to Market Perform, citing slower customer deal activity and AI-related uncertainty.
  • Broader context: The sell-off was company-specific; major indices were only modestly lower, and the stock broke decisively below its prior 52-week low of $28.66.
  • What to watch next: Investors will monitor whether ACV growth rebounds in the second half of 2026, as management indicated the pipeline remains healthy but deals are elongating rather than closing.

Opening Summary

PEGA, the stock of Pegasystems Inc. — a Waltham, Massachusetts-based enterprise software company specializing in customer engagement, digital process automation, and low-code application development — cratered by roughly 14% on Wednesday. The shares traded near $26.60 in the morning session, down sharply from Tuesday's closing price of $30.94. The rout was triggered by a second-quarter earnings report that fell short of Wall Street expectations on both the top and bottom lines, compounded by cautious forward commentary around AI-driven spending delays, a deceleration in Annual Contract Value growth, and a same-day analyst downgrade.

Q2 Earnings Miss Sparks the Sell-Off

Pegasystems reported its Q2 2026 results after the closing bell on Tuesday, and the numbers landed well below consensus. Adjusted earnings per share came in at $0.35, missing the analyst estimate of $0.43 by $0.08 — an 18.6% shortfall. Revenue rose 9% year-over-year to $420.72 million but also missed the Street's expectation of $427.38 million. On a GAAP basis, net income fell to $13.3 million, or $0.08 per share, compared with $30.1 million, or $0.17 per share, in the same quarter a year ago.

While the revenue miss was relatively modest at just 1.6%, the earnings shortfall pointed to weaker operating leverage than the market had priced in. More significantly, the quarter marked the second consecutive period in which both total revenue and subscription revenue fell more than 4% below analyst estimates, reinforcing concerns about the company's execution trajectory.

Slowing ACV Growth and AI-Related Caution

Perhaps the most concerning metric for investors was the sharp deceleration in Annual Contract Value growth. Total ACV grew just 7% year-over-year on a reported basis (8% in constant currency), down from 12% in the first quarter. During the first half of 2026, ACV growth was just 6%, compared with 16% in the first half of 2025 — a dramatic slowdown that raised red flags about the company's near-term momentum.

CEO Alan Trefler attributed the weakness to what he described as "AI market confusion," noting that enterprise customers are wrestling with how artificial intelligence will reshape software development and whether they should build more automation capabilities in-house. Management warned that these headwinds could continue to weigh on ACV growth and cash flow generation through the remainder of 2026. The company also acknowledged that internal go-to-market execution challenges — including change management around a new sales motion — compounded the market-driven headwinds.

On the positive side, Pega Cloud ACV rose 22% year-over-year to $926 million and now accounts for 57% of total ACV. Free cash flow for the first half reached a record $288 million, and the company repurchased 9 million shares for more than $360 million. However, those bright spots were not enough to offset investor anxiety about the deteriorating growth narrative.

Analyst Downgrade Amplifies Downward Pressure

The earnings miss triggered an immediate reaction from the analyst community. Citizens JMP downgraded PEGA from Market Outperform to Market Perform on Wednesday morning, eliminating its price target. The firm cited weaker-than-expected quarterly performance, slower customer deal activity tied to AI-related uncertainty, and a desire to better understand the factors driving purchasing delays among enterprise clients. The downgrade echoed caution from other analysts who had adopted neutral stances heading into the print, and it added institutional weight to the selling pressure.

Market Context and Trading Activity

Wednesday's plunge was overwhelmingly company-specific. The S&P 500 was down roughly 0.4%, the Dow Jones Industrial Average slipped 0.2%, and the Nasdaq Composite fell about 0.9% — none of which explains the magnitude of PEGA's decline. Volume was dramatically elevated, with premarket and early-session activity far exceeding the stock's average daily volume, signaling broad-based institutional repositioning.

Technically, the stock shattered its prior 52-week low of $28.66, a level that had served as a floor during earlier sell-offs. PEGA was already trading well below its 50-day moving average of approximately $32.55 and its 200-day moving average of around $40.24 before the earnings release. The post-earnings gap lower pushed the shares to levels not seen in nearly two and a half years, with the stock now down roughly 48% year-to-date.

Insider Selling Weighs on Sentiment

Adding a layer of unease, SEC filings revealed that Pegasystems executives — including CEO Alan Trefler — completed 21 open-market share sales over the prior six months, with no insider purchases recorded during the same window. While insider selling alone does not signal distress, the complete absence of buying activity has not gone unnoticed by investors at a time when the stock is trading near multi-year lows.

Trending AI Robots

In volatile market environments like the one currently affecting PEGA, traders increasingly turn to data-driven tools to navigate uncertainty. Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots that have demonstrated strong performance under prevailing market conditions. Tickeron hosts hundreds of AI trading bots covering thousands of tickers across diverse strategies, timeframes, and performance metrics, but only the top performers make it into the Trending AI Robots section. These bots vary by approach — from swing trading and trend following to pattern recognition — and can help traders identify opportunities even when individual stocks face turbulence. Exploring the Trending AI Robots page may provide actionable insights for those seeking a systematic edge in today's fast-moving markets.

What Comes Next for PEGA

The path forward for PEGA hinges on whether the delayed deals cited by management materialize in the second half of the year. Management indicated it expects ACV growth to improve, noting that the pipeline remains healthy and that deals are being pushed out rather than lost. However, the company acknowledged that recovering the first-half shortfall will be challenging, and the historically slower summer and third-quarter periods present additional seasonal headwinds.

New product releases, including Pega Infinity '26 and Infinity Studio — which extends Blueprint AI from design into build and deployment — could help shorten sales cycles. The company also reiterated its full-year 2026 free cash flow target of $575 million, though any sustained ACV weakness could pressure that goal. Analysts, despite the downgrade from Citizens JMP, remain broadly constructive with a consensus Moderate Buy rating, though the average price target of roughly $63 now sits far above the current share price. The next major scheduled catalyst will be the third-quarter earnings report, where investors will demand concrete evidence that ACV momentum is stabilizing and that AI-driven deal delays are easing.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: PEGA

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


PEGA in upward trend: 10-day moving average moved above 50-day moving average on August 11, 2026

The 10-day moving average for PEGA crossed bullishly above the 50-day moving average on August 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PEGA's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on PEGA as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PEGA just turned positive on July 29, 2026. Looking at past instances where PEGA's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PEGA advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .

PEGA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

PEGA moved below its 50-day moving average on August 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PEGA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.823) is normal, around the industry mean (28.402). P/E Ratio (19.028) is within average values for comparable stocks, (80.629). Projected Growth (PEG Ratio) (2.989) is also within normal values, averaging (1.710). Dividend Yield (0.004) settles around the average of (0.048) among similar stocks. P/S Ratio (3.466) is also within normal values, averaging (69.501).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PEGA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PEGA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.17B. The market cap for tickers in the group ranges from 291 to 234.43B. SAP holds the highest valuation in this group at 234.43B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 4%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 11%. TEAM experienced the highest price growth at 51%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was -3% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 77
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
PEGA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of customer relationship management software

Industry PackagedSoftware

Profile
Details
Industry
Information Technology Services
Address
225 Wyman Street
Phone
+1 617 374-9600
Employees
5598
Web
https://www.pega.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.